Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report

Turk J Haematol. 2024 Mar 1;41(1):61-63. doi: 10.4274/tjh.galenos.2024.2023.0477. Epub 2024 Feb 15.

Authors

Yu-Han Gao¹, Ming-Hui Duan¹, Jian Li¹, Lu Zhang¹

Affiliation

¹ Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China

No abstract available

Keywords: Idiopathic multicentric Castleman disease; Janus kinase inhibitor; Ruxolitinib; Treatment.

Publication types

Case Reports

MeSH terms

Castleman Disease* / drug therapy
Humans
Nitriles*
Pyrazoles / therapeutic use
Pyrimidines*

Substances

ruxolitinib
Pyrazoles
Nitriles
Pyrimidines

Supplementary concepts

Multi-centric Castleman's Disease